293 related articles for article (PubMed ID: 31446183)
1. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance.
Mahmoud R; Shah SC; Torres J; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Harpaz N; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1518-1527.e3. PubMed ID: 31446183
[TBL] [Abstract][Full Text] [Related]
2. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
[TBL] [Abstract][Full Text] [Related]
3. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
Axelrad JE; Faye A; Slaughter JC; Harpaz N; Itzkowitz SH; Shah SC
Inflamm Bowel Dis; 2022 Jun; 28(6):855-861. PubMed ID: 34319381
[TBL] [Abstract][Full Text] [Related]
4. Systematic review with meta-analysis: incidence and factors for progression to advanced neoplasia in inflammatory bowel disease patients with indefinite and low-grade dysplasia.
Wan J; Wang X; Zhang Y; Chen M; Wang M; Wu K; Liang J
Aliment Pharmacol Ther; 2022 Mar; 55(6):632-644. PubMed ID: 35166389
[TBL] [Abstract][Full Text] [Related]
5. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.
Pekow JR; Hetzel JT; Rothe JA; Hanauer SB; Turner JR; Hart J; Noffsinger A; Huo D; Rubin DT
Inflamm Bowel Dis; 2010 Aug; 16(8):1352-6. PubMed ID: 20027656
[TBL] [Abstract][Full Text] [Related]
6. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
[TBL] [Abstract][Full Text] [Related]
7. Long-term Risk of Advanced Neoplasia After Colonic Low-grade Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
De Jong ME; Van Tilburg SB; Nissen LHC; Kievit W; Nagtegaal ID; Horjus CS; Römkens TEH; Drenth JPH; Hoentjen F; Derikx LAAP
J Crohns Colitis; 2019 Dec; 13(12):1485-1491. PubMed ID: 31175827
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
[No Abstract] [Full Text] [Related]
9. Risk for colorectal neoplasia in patients with inflammatory bowel disease and mucosa indefinite for dysplasia.
Lai KK; Horvath B; Xie H; Wu X; Lewis BL; Pai RK; Plesec T; Patil DT; Gordon IO; Wang Y; Shen B; Goldblum JR; Liu X
Inflamm Bowel Dis; 2015 Feb; 21(2):378-84. PubMed ID: 25569733
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of high-grade dysplasia and colorectal cancer in inflammatory bowel disease patients with recurrent low-grade dysplasia.
de Jong ME; Kanne H; Nissen LHC; Drenth JPH; Derikx LAAP; Hoentjen F
Gastrointest Endosc; 2020 Jun; 91(6):1334-1342.e1. PubMed ID: 31923409
[TBL] [Abstract][Full Text] [Related]
11. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
[TBL] [Abstract][Full Text] [Related]
12. No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases.
Mahmoud R; Shah SC; Ten Hove JR; Torres J; Mooiweer E; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH;
Gastroenterology; 2019 Apr; 156(5):1333-1344.e3. PubMed ID: 30529584
[TBL] [Abstract][Full Text] [Related]
13. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
Singh K; Al Khoury A; Kurti Z; Gonczi L; Reinglas J; Verdon C; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
J Crohns Colitis; 2019 Sep; 13(10):1343-1350. PubMed ID: 30918959
[TBL] [Abstract][Full Text] [Related]
14. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
Zhang R; Lauwers GY; Choi WT
J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
[TBL] [Abstract][Full Text] [Related]
15. Outcome of "indefinite for dysplasia" in inflammatory bowel disease: correlation with DNA flow cytometry and other risk factors of colorectal cancer.
Choi WT; Rabinovitch PS; Wang D; Westerhoff M
Hum Pathol; 2015 Jul; 46(7):939-47. PubMed ID: 25962315
[TBL] [Abstract][Full Text] [Related]
16. Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis.
Fumery M; Dulai PS; Gupta S; Prokop LJ; Ramamoorthy S; Sandborn WJ; Singh S
Clin Gastroenterol Hepatol; 2017 May; 15(5):665-674.e5. PubMed ID: 27916678
[TBL] [Abstract][Full Text] [Related]
17. Quality of Surveillance Impacts the Colitis-Associated Advanced Neoplasia Risk: A Multicenter Case-Control Study.
Te Groen M; Derks M; den Broeder N; Peters C; Dijkstra G; de Vries A; Romkens T; Horjus C; de Boer N; de Jong M; Nagtegaal I; Derikx L; Hoentjen F
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):357-367.e5. PubMed ID: 36572110
[TBL] [Abstract][Full Text] [Related]
18. Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia.
van Schaik FD; ten Kate FJ; Offerhaus GJ; Schipper ME; Vleggaar FP; van der Woude CJ; Stokkers PC; de Jong DJ; Hommes DW; van Bodegraven AA; Siersema PD; Oldenburg B;
Inflamm Bowel Dis; 2011 May; 17(5):1108-16. PubMed ID: 20824815
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic and surgical treatment outcomes of colitis-associated advanced colorectal neoplasia: a multicenter cohort study.
Derks ME; Te Groen M; Peters CP; Dijkstra G; de Vries AC; Romkens TE; Horjus CS; de Boer NK; Bemelman WA; Nagtegaal ID; Derikx LA; Hoentjen F;
Int J Surg; 2023 Jul; 109(7):1961-1969. PubMed ID: 37300890
[TBL] [Abstract][Full Text] [Related]
20. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
